Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
New COVID-19 vaccines have arrived at pharmacies in the Bay Area, designed to target the most recent FLiRT variants that have become dominant this summer. Sooji Nam reports. Website: http://kpix.com/ YouTube: http://www.youtube.com/CBSSanFrancisco Facebook: https://www.facebook.com/CBSSanFrancisco Instagram: https://www.instagram.com/kpixtv/ Twitter: https://twitter.com/KPIXtv
Federal health officials say thousands of updated booster shots are already being shipped around the country.
The first shots in the Biden administration's fall booster campaign could start in days, after a vote by the CDC's advisers.
U.K. regulators are the first in the world to approve a COVID vaccine booster from Moderna that targets two different variants. Tina Kraus reports.
A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Jocelyn Moran reports on parents weighing in on getting their young children vaccinated against COVID once a vaccine gets FDA approval (4-29-2022)